Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...

Related Keywords

Frankfurt ,Brandenburg ,Germany ,Canada ,Toronto ,Ontario ,London ,City Of ,United Kingdom ,Canadian ,John Tse ,Larry Latowsky ,Company Or Canntab ,Canntab Therapeutics Limited ,Cannabis Research ,Frankfurt Stock Exchange ,Canntab Therapeutics ,Technologies Inc ,Katz Group Rexall ,Canadian Community Pharmacies ,Health Canada ,Canadian Securities Exchange ,London Drug Vice President ,Cannabis Standard Processing ,Medical Purposes License ,Cannabis Research License ,Industrial Hemp License ,Cannabis ,Otc ,Mallcap ,Licensing ,